Pharos iBio Co., Ltd. (KOSDAQ: 388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,020
+420 (4.38%)
Sep 11, 2024, 3:00 PM KST

Pharos iBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
129,448191,588----
Enterprise Value
110,134164,210----
Last Close Price
10020.0014830.00----
PE Ratio
--20.26----
PB Ratio
5.666.76----
P/FCF Ratio
-13.24-23.22----
P/OCF Ratio
-14.52-25.84----
EV/EBITDA Ratio
-10.14-17.41----
EV/EBIT Ratio
-9.52-16.23----
EV/FCF Ratio
-10.50-19.90----
Debt / Equity Ratio
0.010.010.02-0.04-0.68-0.33
Debt / FCF Ratio
-0.02-0.04-0.04-0.07-0.11-0.29
Asset Turnover
--0.010.000.02-
Quick Ratio
25.2821.1516.060.560.860.59
Current Ratio
25.9021.5716.530.570.880.64
Return on Equity (ROE)
--38.50%-1825.61%---
Return on Assets (ROA)
--26.12%-28.73%-23.78%-32.64%-
Return on Capital (ROIC)
--27.09%-469.65%---
Earnings Yield
-8.17%-4.62%----
FCF Yield
-8.10%-4.31%----
Buyback Yield / Dilution
-24.42%-36.26%-53.03%-2.65%-1.86%-
Total Shareholder Return
-24.42%-36.26%-53.03%-2.65%-1.86%-
Source: S&P Capital IQ. Standard template. Financial Sources.